Genscript Biotech Corporation (HKG:1548)
18.50
+0.32 (1.76%)
Aug 22, 2025, 3:45 PM HKT
Genscript Biotech Revenue
Genscript Biotech had revenue of $518.77M USD in the half year ending June 30, 2025, with 32.57% growth. This brings the company's revenue in the last twelve months to $828.10M, down -10.43% year-over-year. In the year 2024, Genscript Biotech had annual revenue of $594.49M with 6.07% growth.
Revenue (ttm)
$828.10M
Revenue Growth
-10.43%
P/S Ratio
6.21
Revenue / Employee
$148.72K
Employees
5,568
Market Cap
40.39B HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 594.49M | 34.01M | 6.07% |
Dec 31, 2023 | 560.48M | -65.22M | -10.42% |
Dec 31, 2022 | 625.70M | 135.60M | 27.67% |
Dec 31, 2021 | 490.10M | 99.25M | 25.39% |
Dec 31, 2020 | 390.85M | 117.49M | 42.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
CSPC Pharmaceutical Group | 28.99B |
Genscript Biotech News
- 4 days ago - Genscript Biotech Corporation (GNNSF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - GenScript Biotech Demonstrates Profitable Scale and Strategic Leadership in H1 2025, Establishing Clear Industry Leadership Through Accelerated Growth and Innovation - PRNewsWire
- 22 days ago - GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader - PRNewsWire
- 2 months ago - China’s drug innovators bank on AI to hasten discovery to commercial success - South China Morning Post
- 5 months ago - Genscript Biotech Corporation 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Genscript Biotech Corp (GNNSF) (FY 2024) Earnings Call Highlights: Record Profits and Strategic ... - GuruFocus
- 5 months ago - GenScript Biotech Corporation Reports FY 2024 Results - PRNewsWire
- 9 months ago - The GenScript Biotech Global Forum Makes a Strong Debut in Europe, Highlighting Breakthroughs in Cell and Gene Therapy Development - PRNewsWire